Table 9 (abstract P375). Multivariate analysis of prognostic factors for survival in 186 patients

From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Variable		DFS			OS
	P value	Hazard ratio	95% CI	P value	Hazard ratio	95% CI
CD8+ T-cells	0.006	0.779	0.652-0.930	0.013	0.747	0.593-0.941
Stage	0.033	1.289	1.020-1.628	0.042	1.277	1.009-1.616
TME Immune Types	0.095	0.853	0.707-1.028	0.108	0.859	0.714-1.034
PD-L1	0.420	0.896	0.686-1.170	0.452	0.903	0.692-1.178

Back to article page